Vaccination at school future challenges

Similar documents
Acceptability of universal hepatitis B vaccination among school pupils and parents

Volunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

This is supported by more detailed targets and indicators in the Single Outcome Agreement.

SUBJECT: HPV vaccination programme update

The Silent Disease Inquiry into Hepatitis C in Australia

FAST-TRACK COMMITMENTS TO END AIDS BY 2030

IMMUNISATION PROGRAMMES IN NHS GREATER GLASGOW AND CLYDE

NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH

What can NHS Health Scotland do to reduce health inequalities? Questions for applying the Health Inequalities Action Framework

IFMSA Policy Statement Ending AIDS by 2030

CASE STUDY: Measles Mumps & Rubella vaccination. Health Equity Audit

ENDING AIDS, TB AND MALARIA AS EPIDEMICS

Cancer Awareness & Early Diagnosis Project Examples. Location: Camden (intervention area) and Kensington & Chelsea (control area), London

ROLE SPECIFICATION FOR MACMILLAN GPs

We have a new vaccine: Now what are we going to do with it? Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci

Lincolnshire JSNA: Chlamydia Screening

The National perspective Public Health England s vision, mission and priorities

Mental Health & Wellbeing Strategy

ENDING AIDS, TB AND MALARIA AS EPIDEMICS

Current National Immunisation Schedule Dr Brenda Corcoran National Immunisation Office.

HIV, Hepatitis and TB in Sweden Epidemiological data and prevention activities

Belarus. Public Association Awakening

A Global Strategy Framework. Prepared by the UNAIDS Inter-Agency Working Group on. HIV/AIDS, Schools and Education

Public Health Screening Programmes Annual Report 1 April 2013 to 31 March 2014

Health Promotion Service Project Overview

Prevention and control of hepatitis B and C in the European Region of WHO

Subject: NHS Screening and Immunisation Programmes T

Positive Media Messages on Health and Diet for Parents and Children

VERSION APPROVAL PROCESS NUMBER 1.0 Nina Schwalbe, Managing Director, Policy and Performance

Progress against the HIV Epidemic: is the end in sight?

Cancer prevention and control in the context of an integrated approach

Institutional information. Concepts and definitions

The role of the health system in uptake of the Human Papilloma-virus (HPV) vaccine among adolescents 9-15 years in Mbale district, Eastern Uganda

60TH SESSION OF THE UNITED NATIONS COMMISSION ON HUMAN RIGHTS

CANCER AND VIRUSES OVERVIEW 3 CURRICULUM LINKS AND AIMS 4 BACKGROUND INFORMATION FOR TEACHERS 5 ACTIVITIES 7 STUDENT WORKSHEETS 10

How effective is comprehensive sexuality education in preventing HIV?

Extramural School-Located HPV Vaccination Program Interviews

The road towards universal access

Item No: 6. Meeting Date: Tuesday 12 th December Glasgow City Integration Joint Board Performance Scrutiny Committee

Eradicating cervical cancer. Our role in making it a reality

Pharmacists, the next possible cadre to advancing access to injectable contraceptives. Laila Akhlaghi, PharmD, MPA Sarah Anderson, PharmD

Think About the Link : Campaign Overview. A prevention and education campaign of the Prevent Cancer Foundation

Media centre. WHO Hepatitis B. Key facts. 1 of :12 AM.

Responsibilities in a sexual relationship - Contact tracing

The introduction of HPV testing to cervical screening in Scotland

The new face of diabetes care in New Zealand

Ethnicity as a barrier to screening

The Hepatitis C Action Plan for Scotland: Draft Guidelines for Hepatitis C Care Networks

Outcomes from Local Cancer Campaigns Survey February 2016

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people

National Group for Volunteering in NHS Scotland

Selected vaccine introduction status into routine immunization

Local CQUIN Template School Aged Immunisation Programmes

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

Overcoming barriers. Our strategy for

Teaching British Sign Language in schools

Children and AIDS Fourth Stocktaking Report 2009

HPV Immunisation Statistics Scotland

Every Opportunity in Partnership.. Child & Family Service working in Partnership to increase Human Papilloma Virus (HPV) coverage rates

Involving patients in service improvement activities

Healthy girls, healthy women

Prioritized research questions for adolescent HIV testing, treatment and service delivery

Advancing the National HIV/AIDS Strategy: Housing and the HCCI. Housing Summit Los Angeles, CA

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health

Challenging disadvantage the final evaluation report of Barnardo s Anti-Poverty Strategy Summary

MRCG Strategic Document

Starting with the end in mind: Experience of transitioning to sustainable services (KZN)

Maternal, Child and Reproductive Health Initiative

South Lanarkshire Council. Autism Strategy. Action Plan. Update April 2014

The outlook for hundreds of thousands adolescents is bleak.

A Process Evaluation of the Implementation of ASSIST in Scotland

NHSE London Immunisation 2 year Plan

Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv

Overcoming barriers to cervical screening in Pacific women

State of Access Report Surveying the Facilities for Deaf and Disabled Customers at UK Live Music Venues

Support for Community Sport. Youth Scotland

WHO Secretariat Dr Timothy Armstrong Coordinator, Surveillance and Population-based Prevention Department of Chronic Diseases and Health Promotion

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Overview of Engaging Young Men Project Follow-Up to Recommendations made in the Young Men and Suicide Project Report

1.2. Please refer to our submission dated 27 February for further background information about NDCS.

Cervical screening. Cytology-based screening programmes

Increasing the uptake of MMR in London: executive summary of findings from the social marketing project, November 2009

Combating HIV/AIDS and stigmatisation

INFORMATION PACK FOR CANDIDATES. Foundation for Women s Health Research and Development (FORWARD)

Data Flows for Direct Commissioning v1.54 Activity Reporting Programme Child Immunisations UNIFY Collections: Guidance

Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018

Patient Education, Diabetes Education, Structured Patient Education What does it all really mean to a person with Diabetes?

YOUNG PEOPLE & VOLUNTEERING

TELL ME Communication Kit

Requirements for new trials to examine offtarget. vaccination. Workshop on: Off-target (heterologous/non-specific) effects of vaccination.

TB the disease, its treatment. Tuberculosis. and prevention

HIV/AIDS: The Pandemic

Strategy for Personal and Public Involvement (PPI)

HPV vaccination policies in Slovenia

HPV Immunisation Statistics Scotland

Strengthening Health Systems and Blood Services

Submission by ActionAid Sierra Leone and Marie Stopes Sierra Leone to the OHCHR

Transcription:

Vaccination at school future challenges Dr Claire Cameron Epidemiologist (Immunisation) Health Protection Scotland Prevention and control of viral hepatitis through adolescent health programmes in Europe Ljubljana, Slovenia 15-16 March 2007

Future challenges for school vaccination Why vaccinate at school? Experience of vaccination at school Practicalities Acceptability and uptake Costs Summary and conclusions

Why vaccinate at school? High proportions of adolescents are required to attend school

Enrolment in Secondary Education enrolment in secondary education as a percentage of the population (aged 5-15 years) 100 90 80 70 60 50 40 30 20 10 0 World Central Africa Southeastern Africa Northern Africa Southern Asia Asia Pacific Middle East Eastern Asia South America Eastern Europe North America Western Europe Source: http://www.sasi.group.shef.ac.uk/worldmapper/display.php?selected=200 Japan Developing countries: Stevens W & Walker D. Adolescent vaccination in the developing world: time for serious consideration? Vaccine 2004; 22:781-785 Clements CJ, Abdool-Karim Q, Chang ML, Nkowane B, Esparza J. Breaking new ground--are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents? Vaccine. 2004 Jul 29;22(21-22):2822-6.

Why vaccinate at school? High proportions of adolescents are required to attend school Lower proportions of adolescents routinely attend primary care

Why vaccinate at school? High proportions of adolescents are required to attend school Low proportions of adolescents routinely attend primary care Often higher uptake Often more cost-effective (e.g. Guay et al Effectiveness and cost comparison of two strategies for hepatitis B vaccination of school children. (Can. J. Public Health Rev. 2003; 94:64-67.)

Why vaccinate at school? High proportions of adolescents are required to attend school Low proportions of adolescents routinely attend primary care Often higher uptake Often more cost-effective Integrated opportunities for health promotion activities Concept of health promoting schools being advocated

UNESCO http://portal.unesco.org/education/en/ev.php-url_id=35173&url_do=do_topic&url_section=201.htm European Network of Health Promoting Schools http://www.euro.who.int/enhps WHO Gold RS. The World Health Organisation: school health initiatives. J. School Health. 1990; 60(7):370-8.

Experience of vaccination at school School vaccination in the UK Vaccine Age Duration BCG 10-14 years 1953-2005 Diphtheria/tetanus/polio 13-18 years 1960s-ongoing Rubella (girls only) 13 years 1971-1994 Measles/rubella 5-16 years 1994 MenC 5-18 years 1999-2000

Experience of vaccination at school School vaccination in the UK Vaccine Age Duration BCG 10-14 years 1953-2005 Diphtheria/tetanus/polio 13-18 years 1960s-ongoing Rubella (girls only) 13 years 1971-1994 Measles/rubella 5-16 years 1994 MenC 5-18 years 1999-2000 HepB (Glasgow only) 11-12 years 2001-2

Experience of vaccination at school School vaccination in the UK Vaccine Age Duration BCG 10-14 years 1953-2005 Diphtheria/tetanus/polio 13-18 years 1960s-ongoing Rubella (girls only) 13 years 1971-1994 Measles/rubella 5-16 years 1994 MenC 5-18 years 1999-2000 HepB (Glasgow only) 11-12 years 2001-2

Experience of vaccination at school School vaccination in the UK Vaccine Age Duration BCG 10-14 years 1953-2005 Diphtheria/tetanus/polio 13-18 years 1960s-ongoing Rubella (girls only) 13 years 1971-1994 Measles/rubella 5-16 years 1994 MenC 5-18 years 1999-2000 HepB (Glasgow only) 11-12 years 2001-2 Equity Freedom All schools state and private Free of charge Voluntary Lack of incentives

Practicalities

Practicalities Vaccination Nurse-led in most places; previously more medical input Nurses employed by Community Health Care Partnerships Extra agency nurses sometimes required, especially for campaigns Each school has a named school nurse (1 per 2380 children; RCN 2005) Work in partnership with other stakeholders Immunisation is a core part of nurses service delivery Ongoing training (based on national standards & core curriculum)

Practicalities Administration Administrators also employed by Community Health Care Partnerships Ideal is electronic call-recall system (School Health Module) Some areas still paper-based Logistics Vaccination generally performed in school halls Vaccines delivered from pharmacy, with consumables, that morning

Practicalities Communication / Education Pupils and parents receive information in advance of immunisation Teachers Peer education? Consent forms are sent home for parent s signature Young people s rights are also considered Older pupils may consent themselves

Practicalities Consent Most parents favoured a joint decision with child, but 19% would not take their child s view into consideration 42% agreed that the child should be able to be vaccinated without parental consent; 48% opposed Brabin L, Roberts S, Farzaneh F, et al. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006;24(16):3087-94.

Practicalities Communication / Education Pupils and parents receive information in advance of immunisation Consent forms are sent home for parent s signature Child s rights are also considered Older children may consent themselves Other stakeholders are also informed/consulted Telephone numbers for queries

Practicalities Co-ordination Strong central co-ordination Programme approach with project management methodology Development of auditable national standards for co-ordination NATIONAL IMMUNISATION PROGRAMMES Template for the programme approach for reporting on development and implementation Epidemiology & Surveillance Data Management Service Delivery Public & Professional Communication & Education

Acceptability Focus group discussions in four secondary schools Discussion with S1 pupils (age 11-12 years) and parents Assess perceptions of acceptability and attitudes to HepB vaccination Investigate what would influence uptake Explore reasons for participation and nonparticipation Inform health education material Hinds A, Cameron JC. Acceptability of universal hepatitis B vaccination among school pupils and parents. Communicable Disease and Public Health 2004;7(4):278-82.

Acceptability Schools Most pupils prefer having vaccines at school than in primary care Most parents favour schools, due to perceived children s preferences Pupil: If you see all your friends having it you ll feel more confident. Pupils didn't want to know too far in advance anxiety! Lack of privacy and embarrassment were barriers for a minority HepB Most pupils knew little/nothing about HepB Knowledge that HepB could be spread through piercing and tattooing caused anxiety Parents also had low knowledge Parent: I thought it was just drug users that got it

Risk of HepB Parents realistic about child s future risk Parent: I mean we don t know how promiscuous our children are going to be or if they are going to be drug users or not. We would all hope that they wouldn t be but Vaccination Pupils felt it was unfair that they were not offered vaccine, while young people in other countries were Decision making May still seek advice/reassurance from primary care Concern about side-effects Majority pupils nearly all parents in favour of HepB vaccine Hinds A, Cameron JC. Acceptability of universal hepatitis B vaccination among school pupils and parents. Communicable Disease and Public Health 2004;7(4):278-82.

Uptake High uptake in schools based programmes is achievable HepB dt & OPV MenC 92% consent 91.3%, 89.2% and 80.3% (1, 2 or 3 doses) 86% (2001/2; age 14 years) 90.9-83.4% in Secondary school Uptake varies by age

Vaccine Uptake in MenC Schools Campaign 1999-2000 100 95 90 85 80 75 70 P1 (age 5) P2 (age 6) P3 (age 7) P4 (age 8) P5 (age 9) P6 (age 10) P7 (age 11) S1 (age 12) S2 (age 13) S3 (age 14) S4 (age 15) S5 (age 16) S6 (age 17) Primary School Year Secondary Uptake (%)

Uptake High uptake in schools based programmes is achievable HepB dt & OPV 92% consent 91.3%, 89.2% and 80.3% (1, 2 or 3 doses) 86% (2001/2; age 14 years) MenC 90.9-83.4% in Secondary school Uptake varies by age Uptake can vary by other factors. Lower uptake for: males (78% vs 82% for 3 doses) pupils living in more deprived areas (74% (highly deprived) vs 89% (most affluent) schools with higher absentee rates (74% vs 83%) pupils attending special needs schools (66% vs 80%) schools with more non-caucasian pupils (75% vs 80%) Wallace LW et al. Determinants of adolescent HepB vaccine uptake. Arch Dis Child 2004; 89:1041

Costs Can be more cost-effective than primary care Guay et al. Effectiveness an cost comparison of two strategies for hepatitis B vaccination of schoolchildren. Can J Pub Hlth 2003; 94(1):64 In HepB pilot scheme, 70% economic costs were vaccine costs HepB 30 per course; HPV 200 per course Wallace LA,Young D, Brown A, Cameron JC, Ahmed S, Duff R, Carman WF, Kitchin NRE, Nguyen-Van-Tam JS, Goldberg DJ. Costs of running a universal adolescent hepatitis B vaccination programme. Vaccine 2005; 23:5624-5631.

Summary & conclusions Integration with health promotion, especially sexual health Retention and/or creation of appropriate infrastructures Early engagement with key stakeholders Capacity for electronic call-recall systems Balancing priorities within school health Reduction in inequalities

Thank You HepB Lesley Wallace Syed Ahmed Rina Duff David Goldberg Alison Hinds